The Citizen: Code Pharma is Developing an Antiviral Drug Against Covid-19

Zyon Ayni - The Citizen

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

The Citizen published an article about Code Pharma, a Dutch pharmaceutical company developing a direct antiviral drug against Covid-19. Codivir, a 16-amino-acid synthetic peptide derived from HIV-1 integrase, was first discovered at Hebrew University in Israel. The peptide had a direct antiviral effect against the novel coronavirus Covid-19.

“We have seen good results with the drug”, said Zyon Ayni, CEO and founder of Code Pharma. “At some point during the epidemic, our flagship drug, Codivir, was detected as a very effective antiviral drug against the SARS-CoV-2 family, the virus that causes COVID-19 disease, in a controlled clinical trial in Brazil”.

More To Explore

Zyon Ayni - ynet
Press

Zyon Ayni’s Code Pharma on ynet TV

Codivir, an antiviral medication against COVID-19, was developed by Code Pharma and its Founder and CEO, Zyon Ayni. Dr. Einat Finkelstein, Chief Scientist of the company,